During the past decade, TriHealth Digestive Institute conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "TriHealth Digestive Institute" are "Crohn Disease" (1 trials) and "Ulcerative Colitis and Crohn's Disease" (1 trials). Many other conditions were trialed in "TriHealth Digestive Institute" in a lesser frequency.

Most popular intervention types in "TriHealth Digestive Institute" are "Biological" (1 trials), "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Adalimumab (40 mg)" (1 trials), "Other Biologic Agents" (1 trials), "Placebo for Adalimumab" (1 trials), "Placebo for Ustekinumab" (1 trials) and "Ustekinumab (6 mg/kg)" (1 trials). Other intervention names were less common.

The vast majority of trials in "TriHealth Digestive Institute" are 2 trials for "All" genders.

Currently, there are NaN active trials in "TriHealth Digestive Institute". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in TriHealth Digestive Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in TriHealth Digestive Institute, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".